Aalborg – US Department of Defense has awarded 2N Pharma a grant of 944.000 USD.
2N Pharma is thrilled to announce that the US Department of Defense has awarded 2N Pharma a grant of 944.000 USD. We are extremely grateful for the financial support that will be used to identify biomarkers in ALS patients.
About ALS
ALS is a terrible and always fatal disease that affects people all over the world. Everyone affected by ALS faces a daily challenge, and it has a massive impact on people’s lives. The cause is unknown, the average life expectancy after diagnosis is only 3-5 years, and there is no effective treatment.
Read the article on MedWatch (Danish)